Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the basis of the primary end point, may be published when key planned co-primary or secondary analyses are not yet availabl... Read More
Cancer Research Research Articles
Overview
107845 Articles
Published in last 50 years
Articles published on Cancer Research
Journals
Select journals
Duration
Select duration
108869 Search results
Recency
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
- Journal of Clinical Oncology
- VOL. 40
on Aug 10, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- VOL. 40
on Aug 10, 2022
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the basis of the primary end point, may be published when key planned co-primary or secondary analyses are not yet available... Read More
Editorial: The effects of COVID-19 on cancer research methods & strategies
- Frontiers in Public Health
- VOL. 10
on Aug 10, 2022
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
- Cancers
- VOL. 14
on Aug 9, 2022
Cancer immunotherapy has received more and more attention from cancer researchers over the past few decades. Various methods such as cell therapy, immune checkpoint blockers, and cancer vaccines alone or in combination therapies have achieved relativ... Read More
Efficacy and safety of rituximab as second-line therapy in immune thrombocytopenic purpura based on ethnicity: A descriptive study among the Arabic population
- Qatar Medical Journal
- VOL. 2022
on Aug 9, 2022
Rituximab is used as second-line therapy in patients with immune thrombocytopenic purpura (ITP) who do not respond to first-line management. The response rate for Rituximab is variable in different populations ranging from 30% to 90%. The adverse eff... Read More
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical Trials.
- Journal of the National Cancer Institute
- VOL. 114
on Aug 8, 2022
The objective of this study was to evaluate whether sex- and gender-based analyses and proper sex and gender terminology were used in oncology trials leading to regulatory drug approval. The Food and Drug Administration (FDA) Hematology/Oncology Appr... Read More
PREVALENCE OF SERUM SUBOPTIMAL VITAMIN D3 LEVELS AND ITS CORRELATION WITH TREATMENT OUTCOME, SOCIODEMOGRAPHIC PROFILE AMONG CANCER PATIENTS: A RETROSPECTIVE ANALYSIS
- Asian Journal of Pharmaceutical and Clinical Research
on Aug 7, 2022
Objectives: In areas of etiology and prevention of cancer research, Vitamin D3 is currently one of the most promising agents. By virtue of anti-inflammatory, immunomodulatory, antiangiogenic, and proapoptotic effects, Vitamin D3 may inhibit carcinoge... Read More
Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial
- Frontiers in Oncology
- VOL. 12
on Aug 5, 2022
PurposeThe aim of the current study is to investigate the impact of Baduanjin, a traditional Chinese exercise, on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor (AI) therapy.MethodsA total of 72 breast canc... Read More
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
- Blood
- VOL. 140
on Aug 4, 2022
Abstract The number of patients with primary cutaneous lymphoma (PCL) relative to other non-Hodgkin lymphomas (NHLs) is small and the number of subtypes large. Although clinical trial guidelines have been published for mycosis fungoide... Read More
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels
- Cellular and Molecular Life Sciences
- VOL. 79
on Aug 4, 2022
Identifying new molecular targets for novel anticancer treatments is a major challenge in clinical cancer research. We have shown that cytidine deaminase (CDA) expression is downregulated in about 60% of cancer cells and tissues. In this study, we ai... Read More
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels.
- Cellular and molecular life sciences : CMLS
- VOL. 79
on Aug 4, 2022
Identifying new molecular targets for novel anticancer treatments is a major challenge in clinical cancer research. We have shown that cytidine deaminase (CDA) expression is downregulated in about 60% of cancer cells and tissues. In this study, we ai... Read More
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes
- Virchows Archiv
on Aug 4, 2022
AbstractGastric adenocarcinoma has recently been classified into several subtypes on the basis of molecular profiling, which has been successfully reproduced by immunohistochemistry (IHC) and in situ hybridization (ISH). A series of 73 gastroesophage... Read More
Levels of evidence for the association between different food groups/items consumption and the risk of various cancer sites: an umbrella review
- International Journal of Food Sciences and Nutrition
- VOL. ahead-of-print
on Aug 3, 2022
This study aimed to determine the level of evidence on the association between food groups/items consumption and the risk of different cancer sites from the meta-analyses/pooled analyses of observational studies. A systematic search was executed in ... Read More
In vitro models for head and neck cancer: Current status and future perspective
- Frontiers in Oncology
- VOL. 12
on Aug 3, 2022
The 5-year overall survival rate remains approximately 50% for head and neck (H&N) cancer patients, even though new cancer drugs have been approved for clinical use since 2016. Cancer drug studies are now moving toward the use of three-dimens... Read More
Early assessment of tumor response using 18F-FDG PET/CT after one cycle of systemic therapy in patients with recurrent and metastatic breast cancer.
- Hellenic journal of nuclear medicine
on Aug 3, 2022
This study was conducted to evaluate the usefulness of early assessment of tumor response using fluorine-18-fludeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) after one cycle of systemic therapy in patients with recurre... Read More
Golden Syrian Hamster Models for Cancer Research
- Cells
- VOL. 11
on Aug 3, 2022
The golden Syrian hamster (Mesocricetus auratus) has long been a valuable rodent model of human diseases, especially infectious and metabolic diseases. Hamsters have also been valuable models of several chemically induced cancers such as the DMBA-ind... Read More
Investigating Morphologic Correlates of Driver Gene Mutation Heterogeneity via Deep Learning
- Cancer Research
- VOL. 82
on Aug 3, 2022
Abstract Despite the crucial role of phenotypic and genetic intratumoral heterogeneity in understanding and predicting clinical outcomes for patients with cancer, computational pathology studies have yet to make substantial steps in th... Read More
Research trends and hotspots of breast cancer management during the COVID-19 pandemic: A bibliometric analysis
- Frontiers in Oncology
- VOL. 12
on Aug 3, 2022
BackgroundThe coronavirus disease 2019 (COVID-19) pandemic is disrupting routine medical care of cancer patients, including those who have cancer or are undergoing cancer screening. In this study, breast cancer management during the COVID-19 pandemic... Read More
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
- The Lancet. Oncology
- VOL. 23
on Aug 1, 2022
The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research was held virtually in October, 2021, following published consensus guidelines. The goal of the consensus meeting was to achieve harmonisation on the design ... Read More
A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians
- Journal of Thoracic Oncology
- VOL. 17
on Aug 1, 2022
Although genome-wide association studies have been conducted to investigate genetic variation of lung tumorigenesis, little is known about gene-gene (G× G) interactions that may influence the risk of non-small cell lung cancer (NSCLC). Leveraging a t... Read More